SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

79 hedge funds and large institutions have $464M invested in Syros Pharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$941K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$27.9M
2 +$5.4M
3 +$3.67M
4
Two Sigma Investments
Two Sigma Investments
New York
+$2.63M
5
State Street
State Street
Massachusetts
+$2.05M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$244K
52
$242K
53
$241K
54
$240K
55
$228K
56
$224K
57
$221K
58
$203K
59
$202K
60
$184K
61
$157K
62
$151K
63
$139K
64
$138K
65
$134K
66
$133K
67
$131K
68
$107K
69
$95K
70
$89K
71
$73K
72
$65K
73
$40K
74
$39K
75
$33.3K